1. Efalizumab;Wellington;Am J Clin Dermatol,2005
2. Efalizumab for psoriasis?;Doggrell;Expert Opin Investig Drugs,2004
3. Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis;Gottlieb;J Drugs Dermatol,2004
4. The use of systemic immune moderators in dermatology: an update;Kazlow Stern;Dermatol Clin,2005
5. Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus;Saini;Curr Pharm Des,2005